171 results
Page 4 of 9
8-K
EX-10.1
j9n95ng9
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
8-K
EX-99.1
u9nd ngzt
20 Nov 20
Regulation FD Disclosure
7:36am
S-3ASR
EX-23.1
tem48 hi2259
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
0fffcere6v
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
nhxb wqalmv9q7a
10 Aug 20
Automatic shelf registration
5:01pm
424B5
lmy1l2n34pzkjd
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
8ymhh1np6z85pk
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
027sl34k8 nziict7a
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-99.1
g2jjfq5mkmd3
14 May 20
Adaptimmune Reports Q1 Financial Results
7:37am
8-K
EX-99.1
6b0v4qy73qztmwyv
27 Feb 20
Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update
7:39am
8-K
EX-10.1
7vnsn
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am